What is 'sunscreen doping,' and should we be concerned about it?
UC expert featured in Allure article
The University of Cincinnati's Kelly Dobos was featured in an Allure article discussing "sunscreen doping." The phrase describes brands reportedly not using chemical filters so they can market sunscreens as 100% mineral, only to include ingredients that are not technically chemical filters but function similarly to them.
While suncreens are labeled either "chemical" or "mineral" in stores, Dobos previously noted this describes how the products work rather than whether they are derived from "natural ingredients." Mineral sunscreens create a barrier on the skin to reflect UV rays, while chemical sunscreens are absorbed into the skin and create chemical reactions that lead to repelling UV rays.
Sunscreen doping implies a negative connotation that brands are "cheating," much like athletes using performance-enhancing drugs, by burying the names of certain ingredients on drug facts labels.
Dobos explained the ingredients in question are not sunscreen filters themselves and typically don't provide effective UV protection on their own. But when used combined with an FDA-approved chemical or mineral filter, they can greatly increase UV protection.
The bottom line, Dobos said, is there is not currently enough data to conclude whether these "sunscreen boosters" are inherently safe or unsafe because they have not been formally petitioned as a sunscreen active ingredient to the Food and Drug Administration.
“Sunscreen boosters haven’t been subjected to the gauntlet of safety testing that [FDA-approved UV filters] are currently subject to,” said Dobos, a cosmetic chemist and adjunct instructor in UC's Cosmetic Science Program in the James L. Winkle College of Pharmacy. “While these boosting ingredients may be safe as currently used, we just don’t have the same amount of data.”
Featured photo a top of a person applying sunscreen. Photo/simonkr/iStock.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
UC Board votes to fund design for YMCA renovation
October 28, 2025
At its October 28, 2025 meeting, the University of Cincinnati Board of Trustees approved $5 million in funding to complete all design and pre-construction services required to renovate the interior of a former YMCA building located at 270 Calhoun Street.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.